For the Inventor, By the Inventor

Enter inventor name

Morristown, NJ, United States of America

Gary L Griffiths

USPTO Granted Patents = 63 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 23

Forward Citations = 1,429(Granted Patents)

Forward Citations (Not Self Cited) = 1,311(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Indianapolis, IN (US) (2001 - 2007)
Morristown, NJ (US) (1992 - 2011)
North Potomac, MD (US) (2010 - 2021)

Company Filing History:

Immunomedics, Inc.

The United States of America, As Represented by the Secretary, Department of Health and Human Services

2 out of 832,761

Other

patents

Years Active: 1992-2025

Loading Chart...

Loading Chart...

Areas of Expertise:

Zirconium-89 Oxine Complex

Composite Probes

Anthracycline-Antibody Conjugates

Anti-CD74 Immunoconjugates

Bi-Specific Antibodies

Targeted Combination Immunotherapy

Radiometal-Binding Peptide Analogues

Fluorination of Proteins

Stable Radioiodine Conjugates

Boron Neutron Capture Therapy

Site-Specific Labeling

Positron Emission Tomography

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473307 - Method of preparing zirconium-89 oxine complex (2025-11-18),

2. 11192903 - Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography (2021-12-07),

3. 10556916 - Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography (2020-02-11),

4. 9273089 - Composite probes and use thereof in super resolution methods (2016-03-01),

5. 9107962 - Anthracycline-antibody conjugates for cancer therapy (2015-08-18),

6. 8895013 - Anthracycline-antibody conjugates for cancer therapy (2014-11-25),

7. 8568729 - Anthracycline-antibody conjugates for cancer therapy (2013-10-29),

8. 8547533 - Composite probes and use thereof in super resolution methods (2013-10-01),

9. 8481003 - Anti-CD74 immunoconjugates and methods (2013-07-09),

10. 8361464 - Anthracycline-Antibody Conjugates for Cancer Therapy (2013-01-29),

11. 8343496 - Anti-CD74 immunoconjugates and methods (2013-01-01),

12. 7943343 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2011-05-17),

13. 7931890 - Targeted combination immunotherapy of cancer and infectious diseases (2011-04-26),

14. 7833528 - Use of multispecific, non-covalent complexes for targeted delivery of therapeutics (2010-11-16),

15. 7829064 - Anti-CD74 immunoconjugates and methods (2010-11-09),

Title: The Innovative Journey of Gary L Griffiths

Introduction: Gary L Griffiths, a talented inventor hailing from Morristown, NJ, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Gary L Griffiths holds several patents in various fields, including telecommunications, renewable energy, and consumer electronics. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Gary L Griffiths has a proven track record of turning innovative ideas into successful products. He has worked for leading tech companies, where he spearheaded research and development projects that have resulted in multiple patented inventions.

Collaborations: Throughout his career, Gary L Griffiths has collaborated with top engineers, scientists, and designers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Gary L Griffiths continues to push the boundaries of innovation, with a keen focus on creating sustainable solutions for the future. His passion for technology and dedication to excellence make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…